Countdown to 2021 CBIIC:

James XUE

Chairman of CANbridge Life Sciences Ltd. 

James Xue, PhD, MBA, Founder, Chairman   and CEO of CANbridge, Distinguished Expert for “the Recruitment Program of Global Experts” (known as “the Thousand   Talents Plan”)


Dr. James Xue is a veteran   entrepreneur with extensive experience spans from US to China and from small   biotech to multi-national biopharmaceutical companies. Over the last two   decades, Dr. Xue led or was involved in several start-up companies and   situations as well as managed sizable business and operations that   contributed to his unique insight and deep knowledge in the biotech industry.   In 2012, Dr. Xue founded CANbridge Life Sciences Ltd, a   ventured-back clinical-stage bio-pharmaceutical company focusing on   developing and commercializing innovative oncology treatments/rare disease to   address highly unmet medical needs in China and Asia.


Prior to CANbridge, he was a senior   executive at Genzyme where he spent 10 years in various managerial positions   with increasing responsibilities.  For   five years he was founding general manager of Genzyme China during which he   managed the launch of several life-saving drugs for the treatment of   hematologic cancer and rare metabolic diseases in China including   Thymoglobuline® and Cerezyme®.


Dr. Xue holds a B.S. in Pharmaceutical   Chemistry from Peking University School of Pharmacy, a Ph.D. in Bioorganic   Chemistry from Brown University and a M.B.A. from Darden School of Business,   University of Virginia.